Board Meeting21 Oct 2026, 03:11 pm

Makers Laboratories Board Meeting on Nov 4 to Approve Q2 Results

AI Summary

Makers Laboratories Ltd has announced that its Board of Directors will convene on November 4, 2026. The primary agenda item is to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026. Concurrently, the company has confirmed that the trading window for its securities will remain closed for insiders from October 1, 2026, until 48 hours after the declaration of these financial results, extending to November 6, 2026.

Key Highlights

Board meeting scheduled for November 4, 2026.
To approve Q2 and H1 FY27 unaudited financial results.
Standalone and consolidated results will be presented.
Trading window closure extended until November 6, 2026.

View BSE Filing

MAKERSL

Pharmaceuticals

MAKERS LABORATORIES LTD.-$

Price Impact